Review Article

Pulmonary Hypertension in Children across Africa: The Silent Threat

Table 3

Recommendations for the operability of PAH-CHD [2, 30, 57, 73, 78].

Category 1 (favorable) (clinical)Category 2 (Cath)Category 3 (borderline)Category 4 (unfavorable)

Age<9 months<2 years>2 years
Oxygen saturation>95%If category 1 is absent<90%
Or SPO2 drop by 19% during exercise or PaO2 by >10% which is inoperable
Failure to thriveYesN/A
Signs of heart failureSymptomatic
Recurrent chest infections, plethora and cardiomegaly on chest X-ray
Reduced symptoms, oligemia, and normal cardiothoracic ratio on chest radiograph
SyndromicSyndromic and favorableDown syndromeDown syndrome with features in categories 3 and 4
CyanosisSuggests severe lung disease or intracardiac shuntingCould be hypoxic on pulse oximetryPresent
ECGLeft atrial/ventricular hypertrophyRight atrial enlargement and RVH
Shunt flowLeft to right shuntBidirectionalRight to left
PVRI (WU·m2)N/A<6 (WU·m2)6-8 (WU·m2)>8 WU·m2
PVR/SVRN/A0.30.3-0.5Advanced PH therapy
OptionsPH treatment
Repeat cardiac catheterization
Targeted PH therapy
Repeat cardiac catheterization
OptionsOperateOperate with standard PH protocolIf , operate but patch fenestrate/leave pop off at the atrial septumHigh risk for surgery, fenestrate patch
Inoperable

CHD: congenital heart disease; ECG: electrocardiogram; PAH: pulmonary arterial hypertension; PH: pulmonary hypertension; PVRi: pulmonary vascular resistance index; RVH: right ventricular hypertrophy; SVR: systemic vascular resistance; WU: Wood units.